Delivery Order SPE2DB24D2010-SPE2DB24FZVW6

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,405.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4566868393 - Doxycycline 50 mg Tablet 60s. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of January 9, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $130,147.89, is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), which is a comprehensive procurement vehicle for a wide range of pharmaceutical products and medical supplies. The contract covers the delivery of 4534860299 DOXYCYCLINE 100MG 500S, a generic medication, to...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $20,707.19, is for the delivery of 4,564,945,167 units of Doxycycline 50 mg tablets. This is a firm fixed-price delivery order contract with a completion date of June 20, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award, worth $6,394.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,961,976 doxycycline 50 mg tablets in 60-count packages. The contract type is a delivery order with a firm fixed price and an ultimate completion date of January 17, 2025. This contract award is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $2,381.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,792,342 units of Doxycycline Hyclate 100 mg tablets, a common antibiotic medication, with a completion date of June 4, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,511,468 units of Doxycycline 100mg in 1,000 count containers. The $3,365.38 firm fixed-price Delivery Order contract has a completion date of December 19, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with the ID SPE2DB22D1017|SPE2DB25FF5KR, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,268,153 units of 50 mg Doxycycline tablets in 60-count packages, with a total ceiling value of $6,435.23. The contract is a Firm Fixed Price Delivery Order, with a period of performance ending on February 14, 2025. This award is part...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,164.84 and is a delivery order for 4,567,649,603 units of Doxycycline Hyclate 100 mg tablets. The contract has an ultimate completion date of March 24, 2025 and is a firm fixed-price contract type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $2,727.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564997075 - Doxycycline 50 mg Tablets, 60s, with a completion date of June 26, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,630.73 firm fixed-price delivery order is for the provision of 4,559,305,900 units of Doxycycline Hyclate 100 mg tablets, with a completion date of December 8, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB24FZVW6
    Delivery Order

This federal contract award, valued at $19,844.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026.

The contract is for the delivery of 4565098325 - DOXYCYCLINE 50 MG TABLET 60S, a pharmaceutical product. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen, as the prime contractor, will be responsible for supplying this medical commodity to support military healthcare programs and federal medical institutions. The contract has a period of performance through July 10, 2024.

Generated 5/17/25, 10:12 AM